
In this segment of his SciX interview, Marc Porter explains why every step matters when measuring at picomolar and femtomolar levels, and how switching to proteinase K helped make his group’s tuberculosis work more clinic-ready.
What does the accelerating adoption of PAT-based approaches to pharmaceutical manufacturing mean for the makers and users of spectroscopic systems?
almost 22 years ago
IMS for Cleaning Verification (PDF)almost 22 years ago
Chemometrics and PAT: What Does It All Mean? (PDF)almost 22 years ago
Near-Infrared Chemical Imaging and the PAT Initiative (PDF)





